Timothy N. Clinton

About

Timothy N. Clinton is a urologic oncologist whose research focuses on optimizing surgical outcomes for testicular cancer, upper tract urothelial carcinoma (UTUC), and prostate and bladder cancers. His major contributions include providing contemporary data on the perioperative safety of open retroperitoneal lymph node dissection (O-RPLND) for testicular cancer, a critical component of multimodal treatment, with his 2024 study reporting outcomes from a high-volume center. He has also investigated the impact of the COVID-19 pandemic on ambulatory urologic oncology surgeries, such as robot-assisted laparoscopic prostatectomy (RALP) and transurethral resection of bladder tumor (TURBT), revealing shifts in care delivery. Additionally, his work on trends in management and outcomes following radical nephroureterectomy for UTUC at Memorial Sloan Kettering Cancer Center has informed evolving treatment paradigms. With his most-cited paper accumulating 5 citations, Clinton’s research is foundational for surgeons seeking evidence-based benchmarks. His achievements include advancing the understanding of perioperative care in testicular cancer and adapting surgical practice during public health crises, making him a key voice in urologic oncology.

Research Focus

Key Achievements

Top Papers

1. 1
   Contemporary Perioperative Outcomes of Open Retroperitoneal Lymph Node Dissection for Testicular Cancer

   5 citations · 2024
2. 2
   Impact of COVID-19 pandemic on ambulatory urologic oncology surgeries.

   2 citations · 2023
3. 3
   Trends in management and outcomes in patients with upper tract urothelial carcinoma following radical nephrouretectomy at Memorial Sloan Kettering Cancer Center.

   2 citations · 2020

Key Collaborators

Contact & Links